GALECTIN THERAPEUTICS INC. Proceeds from Issuance of Private Placement
GALECTIN THERAPEUTICS INC. (GALT) reported Proceeds from Issuance of Private Placement of $3.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2017-03-28
- GALECTIN THERAPEUTICS INC. proceeds from issuance of private placement for fiscal 2016 was $3.00M.
- GALECTIN THERAPEUTICS INC. proceeds from issuance of private placement for fiscal 2002 was $2.86M, a 28.82% increase from fiscal 2001.
- GALECTIN THERAPEUTICS INC. proceeds from issuance of private placement for fiscal 2001 was $2.22M.
| Period end | Proceeds from Issuance of Private Placement 0 month | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2016-12-31 | $3.00M 10-K · filed 2017-03-28 | |||
| 2013-08-16 | $3.00M 10-K · filed 2014-03-21 | $3.00M 10-K · filed 2016-03-15 | ||
| 2003-05-31 | $4.67M 10-K · filed 2014-03-21 | |||
| 2003-01-14 | $1.07M 10-K · filed 2014-03-21 | $1.07M 10-K · filed 2013-03-29 | ||
| 2002-12-31 | $2.86M 10-K · filed 2014-03-21 | |||
| 2001-12-31 | $2.22M 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |